MedPath

Oxytocin

Oxytocin Injection, USP (synthetic)

Approved
Approval ID

a9b62187-4141-487c-a9da-f42ad7f9b408

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 30, 2019

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 946499746

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxytocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0641-6115
Application NumberNDA018243
Product Classification
M
Marketing Category
C73594
G
Generic Name
Oxytocin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (4)

OXYTOCINActive
Quantity: 10 [USP'U] in 1 mL
Code: 1JQS135EYN
Classification: ACTIB
CHLOROBUTANOLInactive
Quantity: 500 mg in 1 mL
Code: HM4YQM8WRC
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Oxytocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0641-6114
Application NumberNDA018243
Product Classification
M
Marketing Category
C73594
G
Generic Name
Oxytocin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (4)

OXYTOCINActive
Quantity: 10 [USP'U] in 1 mL
Code: 1JQS135EYN
Classification: ACTIB
CHLOROBUTANOLInactive
Quantity: 500 mg in 1 mL
Code: HM4YQM8WRC
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxytocin - FDA Drug Approval Details